- Home
- Clinical Trials
Alopecia Areata Study Wellington M23
Alopecia Areata Study
Wellington
Help support research aimed at advancing treatments for yourself and others living with alopecia areata. This autoimmune condition causes hair loss and can significantly impact the mental and emotional well-being of those affected. Your involvement could contribute to the development of more effective medications, ultimately enhancing the quality of life for those affected.
Description
What to expect
Study details
Ages
12 to 63 years old
Duration
Variable
Compensation
Participants may be reimbursed for any reasonable travel, parking, and other expenses associated with study visits.
Eligibility Criteria
You may be eligible to take part if you
- Are aged 12 to 63 years of age
- Have been diagnosed with severe alopecia areata
- Have at least 50% hair loss
- Are in generally in good health
- Don’t have a diagnosis of other types of inflammatory scalp, eyebrow, or eyelash disorders, including but not limited to seborrheic dermatitis, scalp psoriasis, atopic dermatitis, and tinea capitis; or
- Have not received the following treatment within the last 4 weeks: Phototherapy, Tanning booth therapy, cryotherapy, laser therapy (e.g., excimer laser) used for alopecia areata on the scalp, intralesional corticosteroid or PRP injections, microneedling, or microtattooing.
Locations
Description
Alopecia areata is a common but often misunderstood condition that causes hair loss. It's an autoimmune disorder where the immune system mistakenly attacks hair follicles, leading to hair falling out in small, usually round patches on the scalp or other parts of the body. This can be distressing for those affected because it can happen suddenly and affect their appearance. While not physically harmful, it can have a significant impact on a person's self-esteem and quality of life.
Currently, there's no approved systemic treatment for people with severe hair loss (alopecia areata), and there's a significant need for more options for both teenagers and adults. An investigational medication has been developed, which could potentially help treat severe hair loss in both age groups. This investigational medication has been approved for various other conditions and is being studied for additional immune-related diseases, including alopecia areata.
What to expect
This clinical trial aims to determine how well two different doses of the investigational medication (a tablet taken by mouth once a day) works in treating the symptoms of severe hair loss in both adults and, in some places, teenagers. This clinical research is designed to find out if the investigational medication is effective, safe, and easy for people to tolerate when compared to a placebo (a dummy pill with no active ingredient).
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
- We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.
- We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.
- Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.
- All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.
- By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.
- Under the Privacy Act 2020, you may ask if we hold personal information on you, you may request access to the information we hold, and you may ask for correction of your personal information. You can ask to be removed from our contact list at any time.
- There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.